Suppr超能文献

中东呼吸综合征3C样蛋白酶和严重急性呼吸综合征3C样蛋白酶催化机制的综合见解

Comprehensive Insights into the Catalytic Mechanism of Middle East Respiratory Syndrome 3C-Like Protease and Severe Acute Respiratory Syndrome 3C-Like Protease.

作者信息

Wang Hao, He Shuai, Deng Weilong, Zhang Ying, Li Guobang, Sun Jixue, Zhao Wei, Guo Yu, Yin Zheng, Li Dongmei, Shang Luqing

机构信息

State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and KLMDASR of Tianjin, Nankai University, No. 38 Tongyan Road, Haihe Education Park, Tianjin 300350, People's Republic of China.

Drug Discovery Center for Infectious Disease, Nankai University, 38 Tongyan Road, Haihe Education Park, Tianjin 300350, People's Republic of China.

出版信息

ACS Catal. 2020;10:5871-5890. doi: 10.1021/acscatal.0c00110. Epub 2020 Apr 28.

Abstract

Coronavirus 3C-like protease (3CL) is a highly conserved cysteine protease employing a catalytic dyad for its functions. 3CL is essential to the viral life cycle and, therefore, is an attractive target for developing antiviral agents. However, the detailed catalytic mechanism of coronavirus 3CL remains largely unknown. We took an integrated approach of employing X-ray crystallography, mutational studies, enzyme kinetics study, and inhibitors to gain insights into the mechanism. Such experimental work is supplemented by computational studies, including the prereaction state analysis, the ab initio calculation of the critical catalytic step, and the molecular dynamic simulation of the wild-type and mutant enzymes. Taken together, such studies allowed us to identify a residue pair (Glu-His) and a conserved His as critical for binding; a conserved GSCGS motif as important for the start of catalysis, a partial negative charge cluster (PNCC) formed by Arg-Tyr-Asp as essential for catalysis, and a conserved water molecule mediating the remote interaction between PNCC and catalytic dyad. The data collected and our insights into the detailed mechanism have allowed us to achieve a good understanding of the difference in catalytic efficiency between 3CL from SARS and MERS, conduct mutational studies to improve the catalytic activity by 8-fold, optimize existing inhibitors to improve the potency by 4-fold, and identify a potential allosteric site for inhibitor design. All such results reinforce each other to support the overall catalytic mechanism proposed herein.

摘要

冠状病毒3C样蛋白酶(3CL)是一种高度保守的半胱氨酸蛋白酶,利用催化二元体发挥其功能。3CL对病毒生命周期至关重要,因此是开发抗病毒药物的一个有吸引力的靶点。然而,冠状病毒3CL的详细催化机制在很大程度上仍然未知。我们采用了X射线晶体学、突变研究、酶动力学研究和抑制剂等综合方法来深入了解其机制。此类实验工作由计算研究补充,包括预反应状态分析、关键催化步骤的从头计算以及野生型和突变型酶的分子动力学模拟。综合起来,这些研究使我们能够确定一对关键的结合残基(Glu-His)和一个保守的His;一个对催化起始很重要的保守GSCGS基序,一个由Arg-Tyr-Asp形成的部分负电荷簇(PNCC)对催化至关重要,以及一个介导PNCC与催化二元体之间远程相互作用的保守水分子。收集到的数据以及我们对详细机制的深入了解,使我们能够很好地理解SARS和MERS的3CL之间催化效率的差异,进行突变研究以将催化活性提高8倍,优化现有抑制剂以将效力提高4倍,并确定一个潜在的变构位点用于抑制剂设计。所有这些结果相互印证,支持本文提出的整体催化机制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验